Disc Medicine Lands Million: Investors React to FDA Catalyst
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Discover methods to keep discipline in updated budgets, such as setting recurring reviews and reinforcing goals after changes.
20,110 articlesA private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Stratasys is stepping into 2025 with a focused plan to diversify revenue, improve margins, and scale software-led ser...
Oil prices surged to a peak near $119 before pulling back, creating a volatile week for markets. Here are three takea...
Three heavyweight asset managers have pulled back sharply on private credit fears. This piece explains why these fina...
Meta Platforms has shown strong top-line momentum, but rising AI-related costs and shifting margins could pressure ea...
When weighing broad tech exposure against a semiconductor tilt, Fidelity's ETF offers lower fees and wider reach. Lea...
A SpaceX public listing could ripple across technology, energy, and investing. Learn how NuScale Power stands to gain...
The S&P 500 is posting its fastest earnings growth in nearly five years, led by under-the-radar firms across multiple...
Greg Abel is steering Berkshire’s AI strategy with a sizable move into Alphabet. This bold bet highlights how mega-ca...
Investors are weighing a megadeal gamble as SpaceX mulls a public listing. Analysts warn that the moonshot rhetoric m...
When wholesale prices rise, most consumer staples stocks feel the pinch. Coca-Cola, however, has shown resilience. Th...
Investors often chase headlines about political timelines. This piece uses history to explore whether the trump bull ...